CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alpha Tau Medical ltd   (DRTS)
Other Ticker:  
 


Alpha Tau Medical Ltd 's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Alpha Tau Medical Ltd 's ROA in the fourth quarter of 2022?
Alpha Tau Medical ltd achieved a return on average assets (ROA) of 28.1 % in its fourth quarter of 2022, which is below Alpha Tau Medical Ltd 's average return on assets, which stands at 46.35%.

ROA has improved compared to 27.09% in the third quarter of 2022, due to net income growth.

However, within the Healthcare sector 35 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from to 146.

What is ROA?


Return On Assets (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Total Assets Change 184.61 % 184.61 % 184.61 % 184.61 % -
Y / Y Net Income Change 23.8 % - - - -
Net Income (TTM) in million 34 27 27 27 27
Return On Assets (TTM) 28.1 % 27.09 % 33.59 % 44.2 % 64.6 %
DRTS's Total Ranking # 146 # # # # 54
Total Assets (TTM) in million 120 120 120 120 42
Seq. Total Assets Change 0 % 0 % 0 % 184.61 % 0 %
Seq. Net Income Change - - - - -

DRTS's 5 Years Annual ROA >> Back to DRTS Management Effectiveness >> Compare DRTS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 36
Overall # 146

Return On Assets Statistics
High Average Low
64.6 %
46.35 %
28.1 %
(Dec 31 2021)   (Dec 31 2022)


Financial Statements
Alpha Tau Medical Ltd 's Assets $ 120 million DRTS's Balance sheet
Alpha Tau Medical Ltd 's Income $ 34 million Quarterly DRTS's Income Statement
DRTS's Income by Division See DRTS's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
FY
Y / Y Total Assets Change 184.61 % - - - -
Total Assets in million 120 42 0 0 0
Y / Y Net Income Change 23.8 % - - - -
Net Income in million 34 27 0 0 0
Return On Assets 28.1 % 64.6 % - - -

DRTS's 5 Years Annual ROA >> Back to DRTS Management Effectiveness >> Compare DRTS ROA to its Competitors



Comment on DRTS's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA deteriorated to 28.1 %, despite annual net income growth of 23.8 % to $33.76 million, from $27.27 million a year ago, as DRTS's assets increase to $120.15 million, by 23.8 %.


More Return On Assets Ratios
DRTS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DRTS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for DRTS's Competitors
Roa for Alpha Tau Medical Ltd 's Suppliers
Return On Assets for DRTS's Customers

You may also want to know
DRTS's Roi DRTS's Inventory Turnover Ratio DRTS's Growth Rates DRTS's Dividend Comparisons
DRTS's Profitability Ratios DRTS's Asset Turnover Ratio DRTS's Dividend Growth
DRTS's Roe DRTS's Valuation Ratios DRTS's Financial Strength Ratios DRTS's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA
Acelrx Pharmaceuticals Inc  75.95 %
Molecular Templates Inc   71.29 %
Ocuphire Pharma Inc   70.19 %
Gamida Cell Ltd   67.32 %
First Wave Biopharma Inc   59.30 %
Kiniksa Pharmaceuticals Ltd   53.88 %
Chemomab Therapeutics Ltd   52.51 %
Biomx Inc   50.44 %
Dariohealth Corp   48.76 %
Denali Therapeutics Inc   45.30 %
Shockwave Medical Inc   45.20 %
Redhill Biopharma Ltd   45.11 %
Molecular Partners Ag  44.94 %
Sensus Healthcare Inc   43.73 %
Check cap Ltd   42.05 %
Intercept Pharmaceuticals inc   41.95 %
Purple Biotech Ltd   39.84 %
Fusion Pharmaceuticals Inc   38.02 %
Harmony Biosciences Holdings inc   31.75 %
Moderna Inc   31.68 %
Assertio Holdings inc   31.36 %
Dynavax Technologies Corporation  29.16 %
Zymeworks Inc   28.45 %
Point Biopharma Global Inc   28.26 %
Alpha Tau Medical ltd   28.10 %
Catalyst Pharmaceuticals Inc   27.17 %
Singular Genomics Systems Inc   26.30 %
Avid Bioservices Inc   26.27 %
Gsk Plc  25.97 %
Mettler Toledo International Inc  25.89 %

Date modified: 2023-03-21T23:50:31+00:00


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071